This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Georgia State University Research Foundation, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Karuna Mittal and a Quantitative Approach to Assessing DCIS Recurrence Risk.
Introduction
Karuna Mittal is an inventor associated with The Georgia State University Research Foundation, Inc. Her patent work addresses the assessment of local recurrence risk in ductal carcinoma in situ (DCIS), a non-invasive breast cancer condition.
Latest Patents
Mittal is associated with 1 patent: “Quantitative Centrosomal Amplification Score to Predict Local Recurrence of Ductal Carcinoma in Situ.” The invention describes evaluating the severity and frequency of numerical and structural centrosome amplification in a tissue sample and using those findings to calculate a centrosomal amplification score (CAS). The score is intended to help characterize a patient’s 10-year risk of local recurrence of DCIS or other carcinoma in situ.
Career Highlights
The described invention applies quantitative analysis to features of centrosome amplification, with the goal of supporting risk profiling for carcinoma in situ. The supplied information identifies Mittal’s association with The Georgia State University Research Foundation, Inc.
Collaborations
The supplied information names Padmashree Rida and Ritu Aneja as coworkers. It does not specify their roles in the patent or the research.
Conclusion
Karuna Mittal’s patent focuses on a quantitative centrosomal amplification score as a potential tool for assessing long-term local recurrence risk in DCIS.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile